101 related articles for article (PubMed ID: 17127488)
1. Rosiglitazone-induced immune thrombocytopenia.
Hauben M; Younus M
Platelets; 2006 Dec; 17(8):591-3. PubMed ID: 17127488
[No Abstract] [Full Text] [Related]
2. Rosiglitazone-induced immune thrombocytopenia.
Liu X; Huang T; Sahud MA
Platelets; 2006 May; 17(3):143-8. PubMed ID: 16702039
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Br J Haematol; 1997 Jul; 98(1):64-7. PubMed ID: 9233565
[TBL] [Abstract][Full Text] [Related]
4. Circulating antiplatelet antibody specificity in children with immune thrombocytopenic purpura at onset.
Biglino P; Perutelli P; Mori PG
Haematologica; 1997; 82(1):127. PubMed ID: 9107104
[No Abstract] [Full Text] [Related]
5. [The impact of platelet membrane autoantibodies on high-dose dexamethasone therapy in patients with idiopathic thrombocytopenic purpura].
Wang R; Qin P; Ji XB; Hou M
Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):619-21. PubMed ID: 19954623
[TBL] [Abstract][Full Text] [Related]
6. Specific autoantibodies to platelet glycoproteins in Epstein-Barr virus-associated immune thrombocytopenia.
Tanaka M; Kamijo T; Koike K; Ueno I; Nakazawa Y; Kurokawa Y; Sakashita K; Komiyama A; Fujisawa K
Int J Hematol; 2003 Aug; 78(2):168-70. PubMed ID: 12953814
[TBL] [Abstract][Full Text] [Related]
7. Predominant autoantibody response to GPIb/IX in a regulatory T-cell-deficient mouse model for immune thrombocytopenia.
Nishimoto T; Satoh T; Simpson EK; Ni H; Kuwana M
J Thromb Haemost; 2013 Feb; 11(2):369-72. PubMed ID: 23176290
[No Abstract] [Full Text] [Related]
8. [Participation of bonth splenic CD(5)(+) and CD(5)(-) B lymphocytes in production of platelet glycoprotein-specific autoantibodies in chronic ITP].
Lu B; Hou M; Lu L; Shi Y; He Q; Ma D; Zhang M
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):460-2. PubMed ID: 12482355
[TBL] [Abstract][Full Text] [Related]
9. Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia.
Yu Y; Hou Y; Zhao Y; Zhou H; Jing F; Liu Y; Peng J; Liu X; Hou M
Br J Haematol; 2021 Jul; 194(1):191-194. PubMed ID: 33993469
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic autoimmune thrombocytopenia: evidence for redistribution of platelet antibodies into the circulation after immunoadsorption treatment.
Leitner GC; Stiegler G; Horvath M; Hoecker P; Sagaster P; Panzer S
Am J Hematol; 2003 May; 73(1):44-7. PubMed ID: 12701120
[TBL] [Abstract][Full Text] [Related]
11. [Study on autoimmune thrombocytopenic purpura related antibody].
Lu L; Hou M; Shi Y; Qin P; Peng J; Zhu YY; Zhang MH
Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):477-9. PubMed ID: 14575592
[TBL] [Abstract][Full Text] [Related]
12. [Management of idiopathic thrombocytopenic purpura (primary immune thrombocytopenia, ITP)].
Kashiwagi H; Tomiyama Y
Rinsho Ketsueki; 2014 Oct; 55(10):2087-94. PubMed ID: 25297775
[No Abstract] [Full Text] [Related]
13. International study to compare antigen-specific methods used for the measurement of antiplatelet autoantibodies.
Berchtold P; Müller D; Beardsley D; Fujisawa K; Kaplan C; Kekomäki R; Lipp E; Morell-Kopp MC; Kiefel V; McMillan R; von dem Borne AE; Imbach P
Br J Haematol; 1997 Mar; 96(3):477-83. PubMed ID: 9054651
[TBL] [Abstract][Full Text] [Related]
14. [Expression of anti-platelet glycoprotein specific antibodies and anti-HLA antibodies in idiopathic thrombocytopenic purpura].
Xia WJ; Ye X; Fu YS; Xu XZ; Chen YK; Ding HQ; Deng J; Luo GP; Xu R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1032-5. PubMed ID: 19698253
[TBL] [Abstract][Full Text] [Related]
15. [Autoimmune (idiopathic) thrombocytopenic purpura].
Tomiyama Y
Rinsho Ketsueki; 2008 Oct; 49(10):1298-305. PubMed ID: 18833913
[No Abstract] [Full Text] [Related]
16. Glycoprotein V: the predominant target antigen in gold-induced autoimmune thrombocytopenia.
Garner SF; Campbell K; Metcalfe P; Keidan J; Huiskes E; Dong JF; López JA; Ouwehand WH
Blood; 2002 Jul; 100(1):344-6. PubMed ID: 12070047
[TBL] [Abstract][Full Text] [Related]
17. Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia.
Li J; van der Wal DE; Zhu G; Xu M; Yougbare I; Ma L; Vadasz B; Carrim N; Grozovsky R; Ruan M; Zhu L; Zeng Q; Tao L; Zhai ZM; Peng J; Hou M; Leytin V; Freedman J; Hoffmeister KM; Ni H
Nat Commun; 2015 Jul; 6():7737. PubMed ID: 26185093
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
19. [Study on the relations between HLA-DRB1 alleles and idiopathic thrombocytopenic purpura in children].
Wang H; Shen B; Yan W; Hou M; Zhu N; Qi H; Hou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):290-4. PubMed ID: 12170464
[TBL] [Abstract][Full Text] [Related]
20. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice.
Nieswandt B; Bergmeier W; Rackebrandt K; Gessner JE; Zirngibl H
Blood; 2000 Oct; 96(7):2520-7. PubMed ID: 11001906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
